Beckman Coulter, Inc. recalls DxC 500i Clinical Analyzer Modules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Beckman Coulter has confirmed a software anomaly on DxI 9000 Access Immunoassay Analyzer and the DxC 500i Clinical Analyzer that may prevent correct application of user-specified manual dilution factors when ordering additional tests for samples already "In Progress" using the same "Sample ID number". This can lead to false low or high patient results and potential delays in reporting, risking erroneous diagnoses if undetected.
- Products
-
- DxC 500i Clinical Analyzer Modules
- Company
- Beckman Coulter, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution.
Nationwide
- Barcodes
149876665450891498766654507215099590742331- Units affected
- 160 units
- About this recall
- DxC 500i Clinical Analyzer Modules, DxC 500 AU Module w/ISE, DxC 500i (Part Number C63522), DxC 500 AU Module, DxC 500i (Part Number C63521), and Access 2 Module, DxC 500i (Part Number C13252)